Genome editing in animals with minimal PAM CRISPR-Cas9 enzymes
© 2022. The Author(s)..
The requirement for Cas nucleases to recognize a specific PAM is a major restriction for genome editing. SpCas9 variants SpG and SpRY, recognizing NGN and NRN PAMs, respectively, have contributed to increase the number of editable genomic sites in cell cultures and plants. However, their use has not been demonstrated in animals. Here we study the nuclease activity of SpG and SpRY by targeting 40 sites in zebrafish and C. elegans. Delivered as mRNA-gRNA or ribonucleoprotein (RNP) complexes, SpG and SpRY were able to induce mutations in vivo, albeit at a lower rate than SpCas9 in equivalent formulations. This lower activity was overcome by optimizing mRNA-gRNA or RNP concentration, leading to mutagenesis at regions inaccessible to SpCas9. We also found that the CRISPRscan algorithm could help to predict SpG and SpRY targets with high activity in vivo. Finally, we applied SpG and SpRY to generate knock-ins by homology-directed repair. Altogether, our results expand the CRISPR-Cas targeting genomic landscape in animals.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
|---|---|
| Enthalten in: |
Nature communications - 13(2022), 1 vom: 12. Mai, Seite 2601 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Vicencio, Jeremy [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
CRISPR-Associated Protein 9 |
|---|
| Anmerkungen: |
Date Completed 17.05.2022 Date Revised 04.01.2024 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1038/s41467-022-30228-4 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM340802030 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM340802030 | ||
| 003 | DE-627 | ||
| 005 | 20240108141536.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41467-022-30228-4 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1248.xml |
| 035 | |a (DE-627)NLM340802030 | ||
| 035 | |a (NLM)35552388 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Vicencio, Jeremy |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Genome editing in animals with minimal PAM CRISPR-Cas9 enzymes |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 17.05.2022 | ||
| 500 | |a Date Revised 04.01.2024 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2022. The Author(s). | ||
| 520 | |a The requirement for Cas nucleases to recognize a specific PAM is a major restriction for genome editing. SpCas9 variants SpG and SpRY, recognizing NGN and NRN PAMs, respectively, have contributed to increase the number of editable genomic sites in cell cultures and plants. However, their use has not been demonstrated in animals. Here we study the nuclease activity of SpG and SpRY by targeting 40 sites in zebrafish and C. elegans. Delivered as mRNA-gRNA or ribonucleoprotein (RNP) complexes, SpG and SpRY were able to induce mutations in vivo, albeit at a lower rate than SpCas9 in equivalent formulations. This lower activity was overcome by optimizing mRNA-gRNA or RNP concentration, leading to mutagenesis at regions inaccessible to SpCas9. We also found that the CRISPRscan algorithm could help to predict SpG and SpRY targets with high activity in vivo. Finally, we applied SpG and SpRY to generate knock-ins by homology-directed repair. Altogether, our results expand the CRISPR-Cas targeting genomic landscape in animals | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 7 | |a RNA, Guide, CRISPR-Cas Systems |2 NLM | |
| 650 | 7 | |a RNA, Messenger |2 NLM | |
| 650 | 7 | |a CRISPR-Associated Protein 9 |2 NLM | |
| 650 | 7 | |a EC 3.1.- |2 NLM | |
| 700 | 1 | |a Sánchez-Bolaños, Carlos |e verfasserin |4 aut | |
| 700 | 1 | |a Moreno-Sánchez, Ismael |e verfasserin |4 aut | |
| 700 | 1 | |a Brena, David |e verfasserin |4 aut | |
| 700 | 1 | |a Vejnar, Charles E |e verfasserin |4 aut | |
| 700 | 1 | |a Kukhtar, Dmytro |e verfasserin |4 aut | |
| 700 | 1 | |a Ruiz-López, Miguel |e verfasserin |4 aut | |
| 700 | 1 | |a Cots-Ponjoan, Mariona |e verfasserin |4 aut | |
| 700 | 1 | |a Rubio, Alejandro |e verfasserin |4 aut | |
| 700 | 1 | |a Melero, Natalia Rodrigo |e verfasserin |4 aut | |
| 700 | 1 | |a Crespo-Cuadrado, Jesús |e verfasserin |4 aut | |
| 700 | 1 | |a Carolis, Carlo |e verfasserin |4 aut | |
| 700 | 1 | |a Pérez-Pulido, Antonio J |e verfasserin |4 aut | |
| 700 | 1 | |a Giráldez, Antonio J |e verfasserin |4 aut | |
| 700 | 1 | |a Kleinstiver, Benjamin P |e verfasserin |4 aut | |
| 700 | 1 | |a Cerón, Julián |e verfasserin |4 aut | |
| 700 | 1 | |a Moreno-Mateos, Miguel A |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Nature communications |d 2010 |g 13(2022), 1 vom: 12. Mai, Seite 2601 |w (DE-627)NLM199274525 |x 2041-1723 |7 nnns |
| 773 | 1 | 8 | |g volume:13 |g year:2022 |g number:1 |g day:12 |g month:05 |g pages:2601 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41467-022-30228-4 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 13 |j 2022 |e 1 |b 12 |c 05 |h 2601 | ||